Home > Insider Trading > Filing (0000899243-20-010617)

Filing Details

Accession Number:: 0000899243-20-010617
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-04-09 18:44:45
Reporting Period:: 2020-04-07

Accepted Time:: 2020-04-09 18:44:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
861838	Idera Pharmaceuticals Inc.	IDRA	Biological Products, (No Disgnostic Substances) (2836)	043072298

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1193366	El Youssef Zein	Pillar Invest Offshore Sal, Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1534428	Pillar Invest Corp	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1783582	Abude Umari	Pillar Invest Offshore Sal Starco Ctr, Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No
1783583	Pillar Partners Foundation, L.p.	Pillar Invest Offshore Sal Starco Ctr Bloc B, 3Rd Floor, Omar Daouk Street Beirut M8 2020-3313	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-04-07	3,039,514	$1.52	6,260,832	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes

Footnotes

On April 7, 2020, upon the consummation of a private placement of the Issuer (the "Private Placement"), Pillar Partners Foundation, L.P. ("Pillar Foundation"), acquired, in the Private Placement, 3,039,514 shares of common stock (the "Pillar Foundation Shares") as well as warrants to purchase 3,039,514 shares of common stock of the Issuer (the "Pillar Foundation Warrants"). The price per share for the Pillar Foundation Shares was $1.52 and the price per Pillar Foundation Warrant was $0.125. The Pillar Foundation Warrants are not exercisable until receipt of shareholder approval for the sufficient increase in its authorized shares of common stock to cover the exercise of the Pillar Foundation Warrants.
Consists of 21,100 shares held directly by Pillar Pharmaceuticals I, L.P. ("Pillar I"), 20,821 shares held directly by Pillar Pharmaceuticals II, L.P. ("Pillar II"), 29,998 shares held directly by Pillar Pharmaceuticals III, L.P. ("Pillar III"), 1,000 shares held directly by Pillar Pharmaceuticals IV, L.P. ("Pillar IV"), 25,000 shares held directly by Pillar Pharmaceuticals V, L.P. ("Pillar V"), 1,392,259 shares held directly by Pillar Pharmaceuticals 6, L.P. ("Pillar 6"), 4,724,008 shares held directly by Pillar Foundation, 6,724 shares held directly by Youssef El Zein and 39,922 shares held directly by Abude Umari.
Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar I, Pillar II, Pillar III, Pillar IV, Pillar V, Pillar 6 and Pillar Foundation (collectively, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.